Susceptibility of MMP3 gene polymorphism to coronary artery disease: A meta-analysis
MMP3 gene polymorphism to coronary artery disease
Abstract
Background: Conclusions on susceptibility of MMP3 -1612 5A/6A to morbid risk of coronary artery disease (CAD) are controversial. This meta-analysis aims to obtain the accurate relationship between them.
Methods: Relevant literatures on susceptibility of MMP3 -1612 5A/6A to morbid risk of CAD published before July 2019 were searched in PubMed, Web of Science, Cochrane Library, CNKI, VIP and Wanfang. Data were extracted from eligible literatures and analyzed by RevMan5.3 and STATA12.0 for calculating OR and corresponding 95% CI. Study selection: A total of 18 literatures reporting MMP3 -1612 5A/6A and CAD were enrolled. Data extraction was conducted by two researches independently. Any disagreement was solved by the third research.
Results: In recessive model (OR=1.3, 95%CI=1.2-1.64, P=0.03) and over-dominant model (OR=1.50, 95%CI=1.14-1.97, P=0.002), MMP3 -1612 5A/6A was correlated to susceptibility of CAD. Subgroup analysis uncovered that in different genetic models, MMP3 -1612 5A/6A was correlated to susceptibility of CAD in East Asian population (mainly Chinese population).
Conclusions: MMP3 -1612 5A/6A is closely linked to morbid risk of CAD. Gene-environment interaction is the research focus in future analyses.
References
1. Li GM, Zhang CL, Rui RP, Sun B, Guo W. Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. Eur Rev Med Pharmaco 2018; 22(11): 3553-69.
2. Ershow AG, Brown LM, Cantor KP. Intake of tapwater and total water by pregnant and lactating women. Am J Public Health 1991; 81(3): 328-34.
3. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Bi 2001; 17: 463-516.
4. Johnson JL, Jackson CL, Angelini GD, George SJ. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscl Throm Vas 1998; 18(11): 1707-15.
5. Mittal B, Mishra A, Srivastava A, Kumar S, Garg N. Matrix metalloproteinases in coronary artery disease. Adv Clin Chem 2014; 64: 1-72.
6. Pleskovic A, Letonja MS, Vujkovac AC, Starcevic JN, Caprnda M, Curilla E, et al. Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus. Vasa 2017; 46(5): 363-9.
7. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 2003; 41(12): 2130-7.
8. Fallah S, Seifi M, Samadikuchaksaraei A. Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism? J Physiol Biochem 2010; 66(4): 359-64.
9. Koch W, de Waha A, Hoppmann P, Schomig A, Kastrati A. Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case-control study and a meta-analysis. Atherosclerosis 2010; 208(1): 171-6.
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama-J Am Med Assoc 2000; 283(15): 2008-12.
11. Beton O, Arslan S, Acar B, Ozbilum N, Berkan O. Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease. Biomed Rep 2016; 5(6): 709-14.
12. Djuric T, Zivkovic M, Radak D, Jekic D, Radak S, Stojkovic L, et al. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 2008; 41(16-17): 1326-9.
13. Ghaderian SM, Akbarzadeh NR, Tabatabaei PA. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coronary Artery Dis 2010; 21(6): 330-5.
14. Pawlik A, Plucinska M, Kopec M, Glabowski D, Czerewaty M, Safranow K. MMP1 and MMP3 gene polymorphisms in patients with acute coronary syndromes. Iubmb Life 2017; 69(11): 850-5.
15. Sakowicz A, Fendler W, Lelonek M, Pietrucha T. Genetic variability and the risk of myocardial infarction in Poles under 45 years of age. Arch Med Sci 2010; 6(2): 160-7.
16. Seifi M, Fallah S, Firoozrai M. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Arch Med Res 2009; 40(7): 600-4.
17. Zhou X, Huang J, Chen J, Su S, Chen R, Gu D. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study. Thromb Haemostasis 2004; 92(4): 867-73.
18. Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, et al. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol 2006; 98(8): 1012-7.
19. Fallah S, Seifi M, Samadikuchaksaraei A. Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism? J Physiol Biochem. 2010; 66(4): 359-64.
20. Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005; 258(5): 411-9.
21. Du JB, Liu Y, Gao J, et al. Correlation between promoter polymorphism and extracellular matrix stability of atherosclerotic plaques. Chinese journal of medical genetics. 2019; 36: 645-8.
22. Gao B, Li ZC. Study on the relationship between plasma level of matrix metalloproteinase-3 and its promoter gene 5A/6A polymorphism and coronary heart disease. Chinese Critical Emergency Medicine. 2004; 2004-09-10(09): 536-9.
23. He CY, Zhou X, Xiong Y, Wang L, Wu J, Yu H. Polymorphism analysis of mmp-3 gene promoter 5A / 6A in patients with acute coronary syndrome. Chinese journal of emergency medicine. 2004; 13: 748-50.
24. Lu H, Hu S, Wang R, Peng W, Wang TT. Correlation between matrix metalloproteinase 3 gene polymorphism and coronary atherosclerotic heart disease in elderly patients. Journal of Clinical and Experimental Medicine. 2018; 17: 1200-3.
25. Meng DM, MAO YM, Chen Q, Geng J, Qin L, Zhao BR, Zhao FM, Cui RZ. Relationship between matrix metalloproteinase gene polymorphism and coronary heart disease. Tianjin Medicine. 2006; 34: 295-8.
26. Xiong Y, Wei XY, Yang XL, Wang L, He, Zhou Xin. Association of matrix metalloproteinase 3 and 12 gene polymorphism with the risk of acute coronary syndrome in han Chinese. Chinese clinical rehabilitation. 2005; 9: 226-8.
27. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003; 59(4): 812-23.
28. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005; 85(1): 1-31.
29. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006; 69(3): 636-45.
30. Humphries SE, Martin S, Cooper J, Miller G. Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men. Ann Hum Genet 2002; 66(Pt 5-6): 343-52.
31. Schwarz A, Haberbosch W, Tillmanns H, Gardemann A. The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease. Dis Markers 2002; 18(3): 121-8.
32. Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K, et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999; 99(21): 2717-9.
33. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2003; 42(8): 1429-37.
34. Xu X, Wang L, Xu C, Zhang P, Yong F, Liu H, et al. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population. Coronary Artery Dis 2013; 24(4): 259-65.
35. Wang J, Xu D, Wu X, Zhou C, Wang H, Guo Y, et al. Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis. Heart 2011; 97(19): 1542-6.
Copyright (c) 2023 Wenwang Liu
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.